LIMN

Conviction 67HealthcareScan · Tue, Sep 8, 2026

Bearish engulfing

LIMN$3.64-1.89%

ResistanceSupportVol 14

Vol MA14 635.9K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Liminatus Pharma, Inc.Biological Products, (No Diagnostic Substances)liminatuspharma.com ↗

Price3.64

Change-1.89%

Gap+0.00%

Rel volume0.00×

Avg volume29.57M

Avg $ vol4.53M

SMA 202.54

SMA 501.09

SMA 2000.6084

Price vs 50+234.90%

Price vs 200+498.24%

MA stackbullish

50/200 crossgolden · 7d

Supertrenddown · 4.93

RSI (14)68

MACD hist-0.00

MACD crossbear · 0d

Stoch %K / %D61 / 62

ADX (14)46

+DI / −DI54 / 23

RSI divergence—

MACD divergence—

ATR %+10.66%

ADR %11.24%

52w high5.16

52w low0.0989

From 52w high-29.46%

Above 52w low+3580.49%

New 52w highNo

SqueezeOff

Bollinger width315.85%

%B0.64

Donchian pos61.28%

Donchian high5.88

Donchian low0.1025

AVWAP (52w high)4.47

vs AVWAP high-18.53%

AVWAP (52w low)0.1505

vs AVWAP low+2318.42%

OBV trendUp

Chaikin MF (20)-0.34

Today vs 20d0.00×

Avg vol (14d)635.9K

Avg vol (20d)29.57M

Avg $ vol (20d)4.53M

Market cap244.46M

RS 3m (vs SPY)+2504.58%

RS 6m (vs SPY)+1483.21%

RS line new highNo

Trend template5/8

Technical rank94.8

1 week-5.70%

1 month+3433.98%

3 months+2481.56%

6 months+1458.89%

1 year+36.33%

YTD+468.13%

P/E-23.95

P/B813.22

P/S—

P/FCF-24.50

EPS-0.4300

Div yield—

ROE—

ROA-299.87%

Debt/Eq4.80

Current1.12

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-187.81%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value245.91M

Revenue—

Net income-1.41M

Gross profit—

Free cash flow-9.98M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out44.88M

Employees1

ListedThu, May 1, 2025

Free float33.49M

Float %74.6%

Short interest10.33M

Days to cover0.2d

Short volume39.0%

Squeeze score41 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank94.8 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LIMN

All disclosures →

No recent disclosed trades by Congress in LIMN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LIMN

No recent insider (Form 4) filings in LIMN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LIMN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.